IGF1 and colorectal carcinoma: The only available meta-analysis of 19 epidemiological studies (5155 cases and 9420 controls) showed that high IGF1 and IGF2 levels significantly increased CRC risk (OR = 1.52, 95% CI: 1.16–2.01 for IGF2) [81].